| Trial ID: | L0003 |
| Source ID: | NCT02194894
|
| Associated Drug: |
Acetaminophen
|
| Title: |
The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients
|
| Acronym: |
--
|
| Status: |
Withdrawn
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease (NAFLD)
|
| Interventions: |
Drug: Acetaminophen
|
| Outcome Measures: |
This pilot study will seek to answer the question of whether or not NAFLD patients are more prone to APAP toxicity and whether or not lower doses should be recommended.|Exploring possible mechanism of acetaminophen liver injury in NAFLD patients
|
| Sponsor/Collaborators: |
University of Southern California
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Not applicable
|
| Enrollment: |
0
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other
|
| Start Date: |
June 2014
|
| Completion Date: |
March 19, 2015
|
| Results First Posted: |
--
|
| Last Update Posted: |
March 30, 2017
|
| Locations: |
USC, Los Angeles, California, United States|USC HCC II (Fatty Liver Clinic), Los Angeles, California, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT02194894
|
